A group of people on a TV show called "Final Trades" talked about which stocks they think are good to buy. They mentioned three companies: AppLovin, Freeport-McMoRan, and CVS Health. AppLovin is doing very well this year, and some analysts think it will keep going up. Freeport-McMoRan is also good because people in China are buying more things that come from the company. Read from source...
- The article title is misleading and sensationalized. It implies that the stocks mentioned are the only ones worth trading or investing in, when in reality there are many other options available in the market. A more accurate title would be "Some Stocks on CNBC's 'Final Trades'"
- The article does not provide any evidence or data to support the claims made by the analysts and traders. For example, it mentions that AppLovin is the number one performing large cap stock of the year, but it does not show how it compares to other large caps in terms of performance, volatility, valuation, etc.
- The article relies heavily on expert opinions and anecdotal evidence, which are not always reliable or objective. For example, Joshua Brown says AppLovin is the number one performing large cap stock of the year so far, but he does not disclose his track record, incentives, or potential conflicts of interest. Similarly, Stephanie Link likes Freeport-McMoRan amid recovery in China, but she does not explain how she defines recovery, what factors influence her decision, or why she chose these stocks over others.
- The article does not address any potential risks or drawbacks associated with the stocks mentioned. For example, it does not mention the regulatory issues facing Freeport-McMoRan in Indonesia, the competitive landscape of AppLovin in the gaming industry, or the valuation challenges of both stocks.
- The article does not provide any actionable insights or recommendations for readers who are interested in trading or investing in these stocks. It only summarizes the views of some experts, but it does not evaluate their credibility, accuracy, or usefulness.
Positive
Reasoning: The article presents three stock picks from CNBC's "Final Trades" segment, and both AppLovin and Freeport-McMoRan are recommended by the analysts. Additionally, the recent analyst upgrades for these two companies suggest a positive outlook on their performance. The only negative aspect mentioned is that Freeport-McMoRan is a top holding in the broader SPDR S&P Metals & Mining ETF, which might imply some market saturation or competition, but this does not seem to deter the analysts from recommending it.